Sonoma Pharmaceuticals, Inc. financial statements
Sonoma Pharmaceuticals, Inc.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.
FY2026
| Revenue | USD 19.53M | 10-K |
| Net income | −USD 3.17M | 10-K |
| Cash and equivalents | USD 2.4M | 10-Q |
| Total debt | USD 842K | EODHD |
Sonoma Pharmaceuticals, Inc. financials on 6ix · Sonoma Pharmaceuticals, Inc. on 6ix